GPCR Company Profile and Key Details

Q: Who are the executives of GPCR?

Dr. Raymond C. Stevens Ph.D.Chief Executive Officer & DirectorDr. Mark A. Bach M.D., Ph.D.Chief Medical OfficerMs. Lani IbarraSenior Vice President of Clinical Devel. OperationsDr. Fang Zhang Ph.D.Executive Vice President & Head of BiologyDr. Yingli Ma Ph.D.Chief Technology OfficerDr. Xichen Lin Ph.D.Chief Scientific OfficerMr. Tony PengSenior Vice President of LegalMs. Melita Sun JungChief Bus. OfficerMr. Jun S. YoonCo- Founder, Chief Financial Officer & Sec.Dr. Hui Lei Ph.D.Senior Vice President of Chemistry

NASDAQ : GPCR

Structure Therapeutics

$68.61

1.63+2.43%

At Close 4:00 PM

59.54

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Structure Therapeutics Inc. (GPCR) stock surged +2.43%, trading at $68.61 on NASDAQ, up from the previous close of $66.98. The stock opened at $66.64, fluctuating between $66.59 and $69.78 in the recent session.

Stock Snapshot

66.98

Prev. Close

3.95B

Market Cap

66.59

Day Low

-18.75

P/E Ratio

-3.66

EPS (TTM)

-1.76

Cash Flow per Share

66.64

Open

57.57M

Number of Shares

69.78

Day High

95.06%

Free Float in %

9.76

Book Value

1.12M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 09, 2026	66.64	69.78	66.59	68.61	1.07M
Jan 08, 2026	65.91	67.51	65.48	66.98	768.54K
Jan 07, 2026	63.67	67.55	63.45	66.25	941.79K
Jan 06, 2026	63.40	68.09	62.01	63.24	1.22M
Jan 05, 2026	68.15	68.25	61.99	62.77	1.27M
Jan 02, 2026	69.77	70.40	65.60	68.12	919.79K
Dec 31, 2025	67.70	69.63	67.34	69.55	899.67K
Dec 30, 2025	67.23	68.88	66.80	67.78	422.5K
Dec 29, 2025	68.00	68.92	66.58	67.38	384.28K
Dec 26, 2025	69.69	69.69	67.25	68.34	465.69K
Dec 24, 2025	71.00	72.00	68.66	69.69	745.37K
Dec 23, 2025	63.21	71.75	63.21	71.29	1.88M
Dec 22, 2025	64.91	65.77	61.87	63.25	1.37M
Dec 19, 2025	66.03	69.30	64.30	64.94	1.82M
Dec 17, 2025	61.50	62.49	59.92	59.97	1.01M
Dec 16, 2025	63.32	64.03	58.84	61.71	2.09M
Dec 15, 2025	67.08	68.56	64.36	64.80	1.4M
Dec 12, 2025	68.61	68.91	65.81	67.06	1.5M
Dec 11, 2025	69.30	72.39	66.90	67.44	2.04M
Dec 10, 2025	67.04	71.50	65.02	68.94	4.19M

Contact Details

South San Francisco, CA 94080

United States

https://structuretx.com 628 229 9277

About Company

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.

Stock Peers

REGN

-4.46-0.56%

Regeneron Pharmaceuticals, Inc.$796.55 ARGX

-7.07997-0.89%

argenx SE$788.49 MDGL

-42.16-7.58%

Madrigal Pharmaceuticals, Inc.$514.06 UTHR

-7.6-1.55%

United Therapeutics Corporation$483.23 VRTX

-5.82-1.24%

Vertex Pharmaceuticals Incorporated$463.86 ALNY

-1.11-0.28%

Alnylam Pharmaceuticals, Inc.$398.29 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-5.93-2.01%

Praxis Precision Medicines, Inc.$288.45 KRYS

12.5+5.02%

Krystal Biotech, Inc.$261.41 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Structure Therapeutics Inc. (GPCR) stock price?

Structure Therapeutics Inc. (NASDAQ: GPCR) stock price is $68.61 in the last trading session. During the trading session, GPCR stock reached the peak price of $69.78 while $66.59 was the lowest point it dropped to. The percentage change in GPCR stock occurred in the recent session was 2.43% while the dollar amount for the price change in GPCR stock was $1.63.

GPCR's industry and sector of operation?

The NASDAQ listed GPCR is part of Biotechnology industry that operates in the broader Healthcare sector. Structure Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GPCR?

Dr. Raymond C. Stevens Ph.D.
Chief Executive Officer & Director
Dr. Mark A. Bach M.D., Ph.D.
Chief Medical Officer
Ms. Lani Ibarra
Senior Vice President of Clinical Devel. Operations
Dr. Fang Zhang Ph.D.
Executive Vice President & Head of Biology
Dr. Yingli Ma Ph.D.
Chief Technology Officer
Dr. Xichen Lin Ph.D.
Chief Scientific Officer
Mr. Tony Peng
Senior Vice President of Legal
Ms. Melita Sun Jung
Chief Bus. Officer
Mr. Jun S. Yoon
Co- Founder, Chief Financial Officer & Sec.
Dr. Hui Lei Ph.D.
Senior Vice President of Chemistry

How GPCR did perform over past 52-week?

GPCR's closing price is 418.99% higher than its 52-week low of $13.22 where as its distance from 52-week high of $94.90 is -27.7%.

How many employees does GPCR have?

Number of GPCR employees currently stands at 163.

Link for GPCR official website?

Official Website of GPCR is: https://structuretx.com

How do I contact GPCR?

GPCR could be contacted at phone 628 229 9277 and can also be accessed through its website. GPCR operates from 611 Gateway Boulevard, South San Francisco, CA 94080, United States.

How many shares of GPCR are traded daily?

GPCR stock volume for the day was 1.12M shares. The average number of GPCR shares traded daily for last 3 months was 1.5M.

What is the market cap of GPCR currently?

The market value of GPCR currently stands at $3.95B with its latest stock price at $68.61 and 57.57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	163
Beta	-2.15
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	163
Beta	-2.15
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

GPCR Company Profile and Key Details

Structure Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways